×
About 378 results

ALLMedicine™ Viral Hemorrhagic Fevers Center

Research & Reviews  173 results

Methanol Fixation, but not Giemsa Staining, Inactivates Ebola and Lassa Viruses in Peri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646817
The American Journal of Tropical Medicine and Hygiene; Relich RF, Feldmann H et. al.

Sep 22nd, 2020 - Diseases caused by many highly pathogenic viruses, including Ebola virus (EBOV) and Lassa virus (LASV), present with nonspecific signs and symptoms that overlap with common tropical diseases such as malaria. Initial diagnostic tests performed on p...

Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431545
Nature Communications; Barnes KG, Lachenauer AE et. al.

Aug 18th, 2020 - Recent outbreaks of viral hemorrhagic fevers (VHFs), including Ebola virus disease (EVD) and Lassa fever (LF), highlight the urgent need for sensitive, deployable tests to diagnose these devastating human diseases. Here we develop CRISPR-Cas13a-ba...

The safety profile of favipiravir should not be the first argument to suspend its evalu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316222
PLoS Neglected Tropical Diseases; Malvy D, Taburet AM et. al.

Jun 25th, 2020 - The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers.|2020|Malvy D,Taburet AM,de Lamballerie X,Mentre F,Extramiana F,|adverse effects,therapeutic use,adverse effects,therapeutic u...

Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734060
Human Vaccines & Immunotherapeutics; Wolfe DN, Taylor MJ et. al.

Apr 10th, 2020 - The 2014-2016 Ebola virus epidemic in West Africa triggered extensive investments from public and private partners in an attempt to slow the spread of disease and bring the outbreak under control. This significantly accelerated the pace of develop...

Dermatologic Manifestations of Viral Hemorrhagic Fevers
https://emedicine.medscape.com/article/1134475-overview

Jan 5th, 2020 - Background Viral hemorrhagic fevers (VHFs) are a group of lethal zoonotic diseases unified by common underlying pathophysiology. These febrile diseases result from infection by enveloped RNA viruses belonging to six taxonomic families: Arenavirida...

see more →

Guidelines  1 results

Assessing Viral Hemorrhagic Fever Risk in a Returning Traveler | Viral Hemorrhagic Fevers (VHFs) | CDC
https://www.cdc.gov/vhf/abroad/assessing-vhf-returning-traveler.html

Oct 18th, 2018 - This CALM algorithm is for use by Emergency Room clinicians in assessing a patient with signs, symptoms, and/or diagnostic findings concerning for a possible viral hemorrhagic fever (VHF).

see more →

Clinicaltrials.gov  191 results

Methanol Fixation, but not Giemsa Staining, Inactivates Ebola and Lassa Viruses in Peri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646817
The American Journal of Tropical Medicine and Hygiene; Relich RF, Feldmann H et. al.

Sep 22nd, 2020 - Diseases caused by many highly pathogenic viruses, including Ebola virus (EBOV) and Lassa virus (LASV), present with nonspecific signs and symptoms that overlap with common tropical diseases such as malaria. Initial diagnostic tests performed on p...

Yellow fever - Diagnosis and treatment - Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/yellow-fever/diagnosis-treatment/drc-20353051

Sep 21st, 2020 - Diagnosis Diagnosing yellow fever based on signs and symptoms can be difficult because early in its course, the infection can be easily confused with malaria, typhoid, dengue fever and other viral hemorrhagic fevers. To diagnose your condition, yo...

Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431545
Nature Communications; Barnes KG, Lachenauer AE et. al.

Aug 18th, 2020 - Recent outbreaks of viral hemorrhagic fevers (VHFs), including Ebola virus disease (EVD) and Lassa fever (LF), highlight the urgent need for sensitive, deployable tests to diagnose these devastating human diseases. Here we develop CRISPR-Cas13a-ba...

The safety profile of favipiravir should not be the first argument to suspend its evalu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316222
PLoS Neglected Tropical Diseases; Malvy D, Taburet AM et. al.

Jun 25th, 2020 - The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers.|2020|Malvy D,Taburet AM,de Lamballerie X,Mentre F,Extramiana F,|adverse effects,therapeutic use,adverse effects,therapeutic u...

Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734060
Human Vaccines & Immunotherapeutics; Wolfe DN, Taylor MJ et. al.

Apr 10th, 2020 - The 2014-2016 Ebola virus epidemic in West Africa triggered extensive investments from public and private partners in an attempt to slow the spread of disease and bring the outbreak under control. This significantly accelerated the pace of develop...

see more →

News  2 results

Assessing Viral Hemorrhagic Fever Risk in a Returning Traveler | Viral Hemorrhagic Fevers (VHFs) | CDC
https://www.cdc.gov/vhf/abroad/assessing-vhf-returning-traveler.html

Oct 18th, 2018 - This CALM algorithm is for use by Emergency Room clinicians in assessing a patient with signs, symptoms, and/or diagnostic findings concerning for a possible viral hemorrhagic fever (VHF).

Hemorrhagic Fever Diagnosis Improved
https://www.medpagetoday.com/infectiousdisease/publichealth/2886

Mar 20th, 2006 - Action Points Explain to patients who ask that they are not likely to ever develop any of these hemorrhagic fevers, but treatment for most is supportive care. Note that accurate and rapid diagnostic testing is important to put in place appropriate...

see more →

Patient Education  11 results see all →